Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies
- 11 March 2009
- journal article
- research article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 9 (1), 58-61
- https://doi.org/10.1016/j.autrev.2009.03.005
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti–Jo‐1 or anti–Ro 52/anti–Ro 60 autoantibodiesArthritis & Rheumatism, 2007
- Autoantibody profiles in the sera of European patients with myositisAnnals Of The Rheumatic Diseases, 2001
- Update on the genetics of the idiopathic inflammatory myopathiesCurrent Opinion in Rheumatology, 2000
- Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositisArthritis & Rheumatism, 1996
- Inclusion body myositis and myopathiesAnnals of Neurology, 1995
- Polymyositis, Dermatomyositis, and Inclusion-Body MyositisNew England Journal of Medicine, 1991
- A New Approach to the Classification of Idiopathic Inflammatory MyopathyMedicine, 1991
- Multiplicity of antibodies in myositis seraArthritis & Rheumatism, 1984
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975